With 170 AI-designed drugs in clinical trials, researchers say 2026 and 2027 will be landmark years for medicine's next frontier

A new study suggests blood biomarkers linked to Alzheimer’s disease could identify early cognitive changes decades before dementia develops, though experts caution against widespread screening in healthy populations

Science is revealing more and more secrets of the superagers, who possess elephant-like memory and a brain impervious to Alzheimer's

A new study highlights three existing drugs—including Viagra, riluzole, and the shingles vaccine—as potential treatments for Alzheimer’s, paving the way for faster, safer therapies through drug repurposing

A Harvard-led study published in Nature found unusually low lithium levels in Alzheimer’s patients and showed in mice that a specific lithium compound may even reverse memory loss, raising cautious hope for future therapies

FTD generally appears between the ages of 45 and 64 and is often misdiagnosed as a psychiatric condition or Alzheimer’s

Cases of dementia or Alzheimer’s are increasing by up to 200% in younger age groups, while decreasing among the elderly in developed countries